Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis

Daniel Z.P. Friedman, Elitza S. Theel, Randall C. Walker, Holenarasipur R. Vikram, Raymund R. Razonable, Paschalis Vergidis

Research output: Contribution to journalArticlepeer-review

Abstract

We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.

Original languageEnglish (US)
Article numberofae114
JournalOpen Forum Infectious Diseases
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2024

Keywords

  • aspergillosis
  • bronchoscopy
  • galactomannan
  • hematopoietic stem cell transplant
  • solid organ transplant

ASJC Scopus subject areas

  • Oncology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis'. Together they form a unique fingerprint.

Cite this